Tobias Neff is an Oncology physician affiliated with Merck & Co.. OpenAlex indexes 67 publications with 2,998 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2012–2015 per NIH RePORTER. The latest:
- Ezh2 in MLL-AF9 mediated acute myeloid leukemia
University of Colorado Denver
FY2015$146,016K08CA154777 - Ezh2 in MLL-AF9 mediated acute myeloid leukemia
University of Colorado Denver
FY2014$146,016K08CA154777 - Ezh2 in MLL-AF9 mediated acute myeloid leukemia
University of Colorado Denver
FY2013$146,016K08CA154777
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ednan Bajwa, MD
Merck & Co.
Annaswamy Raji, MD
Merck & Co.
Ritu Valiyil, MD
Merck & Co.
William F. Keane
Merck & Co.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”